We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of AMRI yet.

AMRI Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2026, worth a combined $22 — unchanged from a quarter earlier.

Fund positioning in AMRI was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Albany Molecular Research Inc (AMRI) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $22 of Albany Molecular Research Inc stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Albany Molecular Research Inc positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.